Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

View the 50 largest pharmaceutical companies in the world listings here

AstraZeneca

AstraZeneca

Rank: 12

Cambridge, U.K.
www.astrazeneca.com

2020 Revenues ($USD) : $26,617,000,000
2020 R&D spend : $5,991,000,000
2020 Number of Employees : 76,100
Fiscal Year End : 12/31/2020
Key People : Pascal Soriot, CEO; Marc Dunoyer, CFO; Katarina Ageborg, EVP, sustainability and chief compliance officer, president of AstraZeneca AB Sweden; Pam Cheng, EVP, operations and information technology; Ruud Dobber, EVP, BioPharmaceuticals business unit; David Fredrickson, EVP, Oncology business unit; Menelas (Mene) Pangalos, EVP, BioPharmaceuticals R&D; Jeff Pott, EVP, human resources and general counsel; Iskra Reic, EVP, Europe and Canada; Leon Wang, EVP, international

AstraZeneca is a Cambridge, U.K.-based company that was launched into the global spotlight last year when its COVID-19 vaccine candidate was one of a number of vaccines that have been widely approved and administered so far to flatten the curve of the pandemic. The EU authorized the AstraZeneca vaccine on Jan. 29 this year, though it has yet to receive U.S. FDA authorization. The World Health Organization granted the vaccine emergency use listing on February 15. In addition to COVID-19 vaccines, the biopharmaceutical company’s R&D efforts focus on oncology, cardiovascular, renal, metabolism, respiratory, immunology and other therapies in its R&D efforts. AstraZeneca received 29 approvals of new medicines or life-cycle management indications in 2020 and announced plans to pick up Alexion Pharmaceuticals in an acquisition deal worth $39 billion. –DK

AstraZeneca scientist

[An AstraZeneca scientist reviews compounds. Image courtesy of AstraZeneca.]

Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE